Dmitriy Berenzon
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 20
- Acute Myeloid Leukemia Research 13
- Chronic Myeloid Leukemia Treatments 6
- Genetics 11
- Myeloproliferative Neoplasms: Diagnosis and Treatment 11
- Co-authors
- Ronald HoffmanBayard L. PowellLeslie R. EllisTimothy S. PardeeJohn MascarenhasHeidi D. KlepinSusan LyerlyScott Isom
- Journals
- Blood (13 papers)Journal of Clinical Oncology (3 papers)Leukemia Research (2 papers)Annals of Hematology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Dmitriy Berenzon
25 papers receiving 528 citations
Peers
Comparison fields: 5 of 59
- Hematology 301
- Genetics 215
- Geriatrics and Gerontology 27
- Cancer Research 73
- Rheumatology 68
Countries citing papers authored by Dmitriy Berenzon
This map shows the geographic impact of Dmitriy Berenzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitriy Berenzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitriy Berenzon more than expected).
Fields of papers citing papers by Dmitriy Berenzon
This network shows the impact of papers produced by Dmitriy Berenzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitriy Berenzon. The network helps show where Dmitriy Berenzon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dmitriy Berenzon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 0 | |
| 2 | 2022 | 0 | |
| 3 | 2018 | 80 | |
| 4 | 2018 | 39 | |
| 5 | 2018 | 44 | |
| 6 | 2017 | 2 | |
| 7 | 2017 | 7 | |
| 8 | 2016 | 4 | |
| 9 | 2015 | 45 | |
| 10 | 2015 | 19 | |
| 11 | 2015 | 2 | |
| 12 | 2015 | 1 | |
| 13 | 2014 | 1 | |
| 14 | 2014 | 18 | |
| 15 | 2013 | 46 | |
| 16 | 2013 | 1 | |
| 17 | 2011 | 17 | |
| 18 | 2010 | 22 | |
| 19 | 2010 | 63 | |
| 20 | 2009 | 1 |
About Dmitriy Berenzon
Dmitriy Berenzon is a scholar working on Hematology, Genetics, Rheumatology, Cancer Research and Oncology, having authored 28 papers that have together received 535 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Eosinophilic Disorders and Syndromes (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Hematology (301 citations), Genetics (215 citations), Geriatrics and Gerontology (27 citations), Cancer Research (73 citations) and Rheumatology (68 citations). Dmitriy Berenzon has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Ronald Hoffman, Bayard L. Powell, Leslie R. Ellis, Timothy S. Pardee, John Mascarenhas, Heidi D. Klepin, Susan Lyerly, Scott Isom, Sarah Dralle and Megan Manuel. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia Research, Annals of Hematology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.